Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sylvia Lin
Institution:
Icahn School of Medicine at Mount Sinai
Observed institution:
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0003-2684-6314
Observed ORCID:
0000-0003-2684-6314
OpenAlex ID:
A5090917562
Multiple myeloma, race, insurance and treatment
2021
·
Himanshu Joshi
, Sylvia Lin
, et al.
·
Cancer Epidemiology
·
20
Insulin resistance and racial disparities in breast cancer prognosis: a multi-center cohort study
2022
·
Emily J Gallagher
, Giampaolo Greco
, et al.
·
Endocrine Related Cancer
·
7
Implementation of a rule-based algorithm to find patients eligible for cancer clinical trials
2024
·
Nina A Bickell
, Benjamin May
, et al.
·
JAMIA Open
·
6
Insulin receptor expression and its association with hyperinsulinemia in triple negative breast cancer
2026
·
Alexis J Engel
, Krupa Samuel
, et al.
·
Journal of the Endocrine Society
·
3
Subjective social status, race, and metabolic syndrome in women with breast cancer
2023
·
Giampaolo Greco
, Nina A. Bickell
, et al.
·
Breast Cancer Research and Treatment
·
2
PDF
Using key stakeholder interviews to inform implementation of a cancer center collaborative intervention to improve clinical trial accruals.
2023
·
Pakhi Goel
, Sylvia Lin
, et al.
·
Journal of Clinical Oncology
·
1
PDF
The great mismatch: Assessing cancer clinical trial accrual rates.
2026
·
Nina A. Bickell
, Radhi Yagnik
, et al.
·
Journal of Clinical Oncology
Investigating reasons patients do not join a cancer clinical trial.
2026
·
Radhi Yagnik
, Parul Agarwal
, et al.
·
Journal of Clinical Oncology
PDF
9260 Insulin Receptor Signaling and Racial Disparities in Triple Negative Breast Cancer
2024
·
Alexis Joy Engel
, Krupa Samuel
, et al.
·
Journal of the Endocrine Society
PDF
9260 Insulin Receptor Signaling And Racial Disparities In Triple Negative Breast Cancer
2024
·
Alexis Joy Engel
, Krupa Samuel
, et al.
·
Journal of the Endocrine Society
Disrupting how we recruit to cancer clinical trials.
2024
·
Nina A. Bickell
, Benjamin May
, et al.
·
Journal of Clinical Oncology
PDF
Diversity, equity, and inclusion in cancer clinical trial enrollment: Laying the groundwork for a cancer center collaborative intervention through key informant interviews.
2022
·
Pakhi Goel
, Megan C. Edmonds
, et al.
·
Journal of Clinical Oncology
Race, subjective social status and metabolic syndrome in women with breast cancer.
2021
·
Giampaolo Greco
, Emily J. Gallagher
, et al.
·
Journal of Clinical Oncology
Electronic vs manual approaches to identify patients from the EHR for cancer clinical trials–what’s feasible
2020
·
Nina A Bickell
, Sylvia Lin
, et al.
·
Journal of Cancer Prevention & Current Research
Are two sites better than one?: Sites of care and quality of myeloma treatment.
2019
·
Anne Renteria
, Sundar Jagannath
, et al.
·
Journal of Clinical Oncology
Racial and insurance disparities in multiple myeloma management in a referral center.
2019
·
Anne Renteria
, Sundar Jagannath
, et al.
·
Journal of Clinical Oncology
A non-interventional, observational registry of adult patients with multiple myeloma treated with Revlimid (lenalidomide) in China: interim analysis
2015
·
Shang‐Yi Huang
, Ya‐Hsuan Yu
, et al.
Show more works
View as search
Works count:
17
Citation count:
39
H-index:
3
I10-index:
1
Year
Topic
Type